MT
Therapeutic Areas
Breye Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Danegaptide | Diabetic Retinopathy | Phase 2 |
| Oral P2X7 Receptor Antagonists | Diabetic Retinopathy / Age-related Macular Degeneration | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Danegaptide | Diabetic Retinopathy | Phase 2 |
| Oral P2X7 Receptor Antagonists | Diabetic Retinopathy / Age-related Macular Degeneration | Preclinical |